pms-Ranitidine 150mg (2020-08-28)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
pms-Ranitidine 150mg
| Lot or serial number | Brand name | Companies | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| 619003 | pms-Ranitidine 150mg | - Recalling Firm
- Pharmascience Inc.
- 611 ave Royalmount suite 100
- Montreal
- H4P 2T4
- Quebec
- CANADA
- Marketing Authorization Holder
- Pharmascience Inc.
- 611 ave Royalmount suite 100
- Montreal
- H4P 2T4
- Quebec
- CANADA
| DIN 02242453 | Tablet | Ranitidine Hydrochloride 150mg |
Presence of N-nitrosodimethylamine (NDMA) near the interim acceptable concentration limit in affected lot.
Wholesalers, Retailers, Healthcare establishments